हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Fables of Facades
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Advertisement
X
News
Sanofi India
Sanofi India News
Medicines
22 Apr 2017
Combiflam, D-Cold Total among 60 other medicines substandard, declares drug regulator
In total, the CDSCO has issued a drug alert for 60 medicines, including five aforementioned drugs, as they failed different quality tests in March 2017, the Indian Express noted.
Combiflam
18 Dec 2016
Combiflam under drug dept's radar, chemists start withdrawing tablets
Chemists and distributors of the commonly used over-the-counter medicine Combiflam are recalling the medicine after a sample of batch number 6 NA 0347 of the medicine failed a disintegration test conducted in the UP government's laboratory in Lucknow.
Vijay Mallya
23 Mar 2016
Will retire from Chairmanship of Sanofi India: Vijay Mallya
Beleaguered liquor baron Vijay Mallya Wednesday announced he will retire as Chairman of Sanofi India and will not seek reelection as a director of the drug maker, nearly a month after he signed a sweetheart deal with Diageo to step down as Chairman of United Spirits Ltd.
Vijay Mallya
14 Mar 2016
Vijay Mallya's board position at Bayer, Sanofi shaky!
With SEBI barring wilful defaulters from board positions at listed companies, the beleaguered Vijay Mallya may be left with no choice but to exit boards of Bayer Cropsciences and Sanofi India in addition to other entities of his UB Group.
Sanofi India
21 Jul 2015
Sanofi India Q2 net up 12% at Rs 64.2 crore
Drug firm Sanofi India Tuesday reported a 11.65 percent rise in its standalone net profit at Rs 64.2 crore during second quarter ended June 30, 2015.
681865
1
0
Loading...
Trending news
DNA Video
DNA: Scuffle Over Article 370 in Jammu & Kashmir Assembly: Why Was Abdullah Smiling?
DNA Video
DNA: Secret Strategy Revealed Ahead of Maharashtra Elections?
DNA Video
DNA: What is Bhagwa-e-Hind?
DNA Video
DNA: Trump-Modi Friendship: Pakistan’s Worries Grow
DNA Video
DNA: Trump’s Victory: What Changes Are Coming?
DNA Video
DNA: Yogi’s Bulldozer Politics in Maharashtra
DNA Video
DNA: Article 370 - CM Abdullah’s Gamble Falls Short?
DNA Video
DNA: Supreme Court Upholds Validity of UP Madrasa Act
DNA Video
DNA: US Presidential Elections and its Global Implications
DNA Video
DNA: Yogi Adityanath’s Winning Formula for Upcoming Elections!
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK